CRISPR Shreds Undruggable Cancer Cells with Precision

“Guardian of the genome,” p53 is now therapeutically accessible using CRISPR-based technology from Jennifer Doudna’s lab. The approach uses RNA signatures to identify and destroy traditionally undruggable cancer cells.

The post CRISPR Shreds Undruggable Cancer Cells with Precision appeared first on GEN - Genetic Engineering and Biotechnology News.